Advertisement
TG Therapeutics, Inc.

TG Therapeutics, Inc. (TGTX) Stock Overview

Explore TG Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TGTX●NASDAQ
HealthcareBiotechnology
$40.56
$0.45(1.12%)
U.S. Market opens in 16h 6m
Advertisement

TG Therapeutics, Inc. (TGTX)

Meyka AI Score

Z

Key Financials

Market Cap6.2B
P/E Ratio12.49
EPS (TTM)$2.86
ROE0.87%
Fundamental Analysis

AI Price Forecasts

1 Month$26.29
3 Months$28.80
1 Year Target$41.60

TGTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TG Therapeutics, Inc. (TGTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $41.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.49 and a market capitalization of 6.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.12%
5-Day Change
4.51%
1-Month Change
13.58%
3-Month Change
38.95%
6-Month Change
29.25%
Year-to-Date (YTD) Change
36.06%
1-Year Change
9.53%
3-Year Change
56.91%
5-Year Change
15.33%
All-Time (Max) Change
-81.97%

Contact Information

https://www.tgtherapeutics.com
212 554 4484
2 Gansevoort Street, Morrisville, NY, 10014

Company Facts

352 Employees
IPO DateMay 3, 2010
CountryUS
Actively Trading

Frequently Asked Questions